Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
31.65
+0.55 (1.77%)
At close: Mar 6, 2026

SHA:688139 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,3292,2742,2722,8552,119
Other Revenue
-9.859.248.627.31
2,3292,2842,2812,8642,126
Revenue Growth (YoY)
1.96%0.13%-20.36%34.72%51.63%
Cost of Revenue
-1,1901,1741,4901,061
Gross Profit
2,3291,0941,1071,3741,065
Selling, General & Admin
-471.73476.68513.72388.03
Research & Development
-306.17320.64292.47236.31
Other Operating Expenses
2,062-6.48-7.252.341.63
Operating Expenses
2,062787.08793.97809.08622.71
Operating Income
266.34306.58312.95564.67441.98
Interest Expense
--3.41-3.51-2.69-2.89
Interest & Investment Income
-71.46118.6495.02483.95
Currency Exchange Gain (Loss)
-4.46-7.723.584.14
Other Non Operating Income (Expenses)
-1.58-1.83-1.68-1.490.56
EBT Excluding Unusual Items
264.76377.25418.67659.1927.74
Gain (Loss) on Sale of Investments
-5.472.06-7.0110.21
Gain (Loss) on Sale of Assets
-0.23-1.6-0.76-0.52
Asset Writedown
--1.86-2.36--
Other Unusual Items
-20.8717.722423.44
Pretax Income
264.76401.96434.49675.34960.87
Income Tax Expense
14.0320.9522.4363.36111.7
Earnings From Continuing Operations
250.73381.01412.06611.97849.17
Minority Interest in Earnings
--14.38-5.99-11.18-4.14
Net Income
250.73366.63406.07600.79845.04
Net Income to Common
250.73366.63406.07600.79845.04
Net Income Growth
-31.61%-9.71%-32.41%-28.90%121.82%
Shares Outstanding (Basic)
313316317318316
Shares Outstanding (Diluted)
313316317318318
Shares Change (YoY)
-0.84%-0.37%-0.20%0.06%-2.43%
EPS (Basic)
0.801.161.281.892.67
EPS (Diluted)
0.801.161.281.892.66
EPS Growth
-31.03%-9.38%-32.27%-28.95%127.35%
Free Cash Flow
-164.9672.08338.18387.11
Free Cash Flow Per Share
-0.520.231.061.22
Dividend Per Share
-0.4700.5150.4500.500
Dividend Growth
--8.74%14.44%-10.02%31.61%
Gross Margin
100.00%47.89%48.53%47.97%50.08%
Operating Margin
11.44%13.42%13.72%19.72%20.79%
Profit Margin
10.77%16.05%17.80%20.98%39.75%
Free Cash Flow Margin
-7.22%3.16%11.81%18.21%
EBITDA
371.14411.38410.67626.73491.15
EBITDA Margin
15.94%18.01%18.00%21.88%23.10%
D&A For EBITDA
104.8104.897.7262.0649.17
EBIT
266.34306.58312.95564.67441.98
EBIT Margin
11.44%13.42%13.72%19.72%20.79%
Effective Tax Rate
5.30%5.21%5.16%9.38%11.63%
Revenue as Reported
-2,2842,2812,8642,126
Advertising Expenses
-24.8831.8225.4114.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.